4Moving Biotech targets inflammation in knee osteoarthritis trial

Phase 2a study completes enrollment as biotech tests whether treating joint inflammation could slow osteoarthritis, not just ease pain. Mention GLP-1 today and most people immediately think of weight loss. Drugs like Ozempic and Wegovy have transformed the conversation around obesity and diabetes, becoming some of the biggest medical success stories of the decade. But […] The post 4Moving Biotech targets inflammation in knee osteoarthritis trial appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.